Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

83.60
Delayed Data
As of Aug 03
 +5.38 / +6.88%
Today’s Change
31.99
Today|||52-Week Range
91.77
+95.74%
Year-to-Date
Ultragenyx Pharmaceutical Inc. 2020 Q2 - Results - Earnings Call Presentation
Jul 31 / Seeking Alpha - Paid Partner Content
Ultragenyx Pharmaceutical Q2 2020 Earnings Preview
Jul 29 / Seeking Alpha - Paid Partner Content
Ultragenyx Pharmaceutical Inc (RARE) Q2 2020 Earnings Call Transcript
Jul 31 / MotleyFool.com - Paid Partner Content
Notable earnings after Thursday's close
Jul 29 / Seeking Alpha - Paid Partner Content
Ultragenyx Pharmaceutical Inc.'s (RARE) CEO Emil Kakkis on Q2 2020 Results - Earnings Call Transcript
Jul 30 / Seeking Alpha - Paid Partner Content
European advisory group backs expanded use of Crysvita
Jul 24 / Seeking Alpha - Paid Partner Content
Ultragenyx Pharmaceutical EPS beats by $1.94, beats on revenue
Jul 30 / Seeking Alpha - Paid Partner Content